Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

119.00p
   
  • Change Today:
      2.50p
  • 52 Week High: 150.00p
  • 52 Week Low: 108.00p
  • Currency: UK Pounds
  • Shares Issued: 84.81m
  • Volume: 12,199
  • Market Cap: £100.93m
  • RiskGrade: 196
  • Beta: 0.00

Diaceutics appoints new VP of marketing

By Josh White

Date: Tuesday 09 Apr 2024

LONDON (ShareCast) - (Sharecast News) - Diaceutics, a technology and solutions provider catering to the pharmaceutical and biotech industry, announced the appointment of Amie Mc Neice as vice-president of marketing on Tuesday.
The AIM-traded firm said Mc Neice, with a background in senior marketing and business development roles at organisations including Almac Group, Fibrus and Kingspan, would bring extensive leadership experience to her new role.

In her capacity as vice-president of marketing, she would spearhead the execution of Diaceutics' three-year marketing vision, focusing on brand positioning, messaging, and the integration of marketing automation.

Notably, her experience in collaborating with US pharma customers would be instrumental in furthering Diaceutics' market presence.

"I am delighted to welcome Amie to the team at Diaceutics," said chief commercial officer Jillian Beggs.

"Our continued investment in sales and marketing supports our mission to provide the data, technology solutions and insights that enable our pharma and biotech customers revolutionise the commercialisation of their products and ultimately improve patient outcomes."

Aligned with its commitment to expanding sales and marketing capabilities in the US and Europe through 2024, Diaceutics said it was "dedicated" to bolstering its team with top-tier talent.

Additionally, it was continuing to invest in product development, exemplified by the ongoing expansion of its product management team in 2024.

The board said the team would play a pivotal role in executing the company's product roadmap and coordinating various product activities across data, scientific and medical services, engagement solutions, engineering, and marketing.

"I have long admired Diaceutics and look forward to working with the team as we expand our sales and marketing capabilities and serve our customers' needs across the US and Europe," commented Amie Mc Neice.

At 1436 BST, shares in Diaceutics were up 0.03% at 104.03p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 119.00p
Change Today 2.50p
% Change 2.15 %
52 Week High 150.00p
52 Week Low 108.00p
Volume 12,199
Shares Issued 84.81m
Market Cap £100.93m
Beta 0.00
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.05% below the market average30.05% below the market average30.05% below the market average30.05% below the market average30.05% below the market average
45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average
Price Trend
18.16% below the market average18.16% below the market average18.16% below the market average18.16% below the market average18.16% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Income Not Available
Growth
44.93% above the market average44.93% above the market average44.93% above the market average44.93% above the market average44.93% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

Diaceutics Dividends

No dividends found

Trades for 11-Jul-2025

Time Volume / Share Price
16:35 3,724 @ 119.00p
16:35 3,724 @ 119.00p
14:53 416 @ 118.50p
14:17 3,000 @ 118.40p
12:26 4,238 @ 118.40p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page